發明
美國
15/842,910
US 10,583,123 B2
Method for the treatment of ATG4-related disorders
國立清華大學
2020/03/10
本發明涉及ATG4相關病症的領域。更具體地,本發明涉及治療ATG4B相關病症的方法,包括投予個體有效劑量的噻康唑的步驟。本發明還涉及增加投予個體對癌症治療的應答性的方法,其包括抑制細胞中的ATG4B活性,所述方法包括給投予個體施用有效劑量的噻康唑。本發明還涉及增強或誘導癌細胞面對包括但不限於細胞毒性、化學敏感性或癌症 - 飢餓敏感性所構成群組其中之一種以上的反應的方法,所述方法包括透過抑制ATG4B活性給投予個體施用有效量的噻康唑。 The present invention relates to the area of ATG4-related disorders. More particularly, the present invention relates to a method of treating an ATG4B-related disorder comprising a step of administering a subject with an effective amount of tioconazole. The present invention relates also to a method of increasing a subject's responsiveness to a therapy for a cancer comprising inhibiting ATG4B activity in a cell, said method comprising administering to the subject an effective amount of tioconazole. The present invention also relates to a method for enhancing or inducing a response selected from the group consisting of cytotoxicity, chemosensitivity or cancer-starvation sensitivity in a cancer cell, said method comprising administering to a subject an effective amount of tioconazole by inhibiting ATG4B activity.
智財技轉組
03-5715131-62219
版權所有 © 國家科學及技術委員會 National Science and Technology Council All Rights Reserved.
建議使用IE 11或以上版本瀏覽器,最佳瀏覽解析度為1024x768以上|政府網站資料開放宣告
主辦單位:國家科學及技術委員會 執行單位:台灣經濟研究院 網站維護:台灣經濟研究院